Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-08-07
2007-08-07
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S009100, C530S300000, C530S317000, C530S321000, C530S333000
Reexamination Certificate
active
10469060
ABSTRACT:
Template-fixed β-hairpin peptidomimetics of the general formulae (I) and (II) wherein Z, Z1 and Z2 are template-fixed chains of 8 to 16 α-amino acid residues which, depending on their positions in the chain (counted starting from the N-terminal amino acid) are Gly, or Pro, or of certain types which, as the remaining symbols in the above formulae, are defined in the description and the claims, and salts thereof, have the property to inhibit the growth of or to kill microorganisms and cancer cells. They can be used as disinfectants for foodstuffs, cosmetics, medicaments or other nutrient-containing materials or as medicaments to treat or prevent infections or diseases related to such infections and/or cancer. These β-hairpin peptidomimetics can be manufactured by a process which is based on a mixed solid- and solution phase synthetic strategy
REFERENCES:
patent: 4698327 (1987-10-01), Nagarajan et al.
patent: 5916872 (1999-06-01), Conway et al.
patent: 6878804 (2005-04-01), Robinson et al.
patent: WO 01/16161 (2001-03-01), None
J. Rudinger. In: Peptide Hormones, JA Parsons, Ed. (1976) 1-7.
D.E. Smilek, et al. Proc. Natl. Acad. Sci. USA (1991) 88, pp. 9633-9637.
W.S. Messer, “Vasopressin and Oxytocin”, web document updated Apr. 3, 2000; <http://www.neurosci.pharm.utoledo.edu/MBC3320/vasopressin.htm>; 5 pages.
S. Rudikoff, et al. Proc. Natl. Acad. Sci. USA (1982) 79, pp. 1979-7983.
J. Späth, et al. Helv. Chim. Acta (1998) 81, pp. 1726-1738.
L. Jiang, et al. Helv. Chim. Acta (2000) 83, pp. 3097-3112.
J.C. J. Barna and D.H. Williams, “The structure and Mode of Action of Glycopeptide Antibiotics of the Vancomycin Group”, Ann. Rev. Microbiol. 38, p. 339-357, 1984.
K.L. Piers and R.E.W. Hancock, “The Interaction of a Recombinant Cecropin/Melittin Hybrid Peptide with the Outer Memberane ofPseudomonas aeruginosa”, Molecular Microbiology 194, 12, 951-958, see especially p. 954: Interaction of CEME with LPS.
K. Matsukaki, “Why and how are peptide-lipid interactions utilized for self Defense: Magainins and tachyplesins as archetypes”, Biochimica et Biophysica Acta 1462 (1999), 1-10, particularly p. 3 et seq.
L. Zhang et al., “Interaction of Polyphemusin I and Structural Analogs with Bacterial Membranes, Lipopolysaccharide, and Lipid Monolayers”, Biochemistry 2000, 39, 14504-14514.
R. Gallo, K.M. Huttner, “Antimicrobial Peptides: An Emerging Concept in Cutaneous Biology”, The Journal of Investigative Dermatology 111,739-743, 1998, see especially pp. 41 et seq.: Mechanism of action, see Fig. 1.
Y. Shai, “Mechanism of the binding, insertion and destabilization of phospholipids bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides”, Biochim Biophys Acta 1999, 1462, 55-70.
A. Tossi et al., “Amphipatic, α-Helical Antimicrobial Peptides”, Biopolymers 200, 55, 4-30.
M. Wu et al., “Mechanism of Interaction of Different Classes of Cationic Antimicrobial Peptides with Planar Bilayers and with the Cytoplasmic Membrane ofEsherichia coli”, Biochemisyry 1999, 38, 7235-7242.
Y. Shai, “Mode of Action of Membrane Active Antimicrobial Peptides”, Biopolymers 66, 236-248, 2002.
S.C. Shankaramma, et al., “Macrocyclic Hairpin Memetics of the Cationic Antimicrobial Peptide Protegrin 1: A New Family of Broad-Spectrum Antibiotics”, ChemBioChem 2002, 3, 1126-1133.
J.A. Robinson, et al. “Properties and structure-activity studies of cyclic β-hairpin peptidommetics based on the cationic antimicrobial peptide protegrin I”, Bioorganic & Medicinal Chemistry 13 (2005) 2055-2064.
Favre et al.; Structural Mimicry of Canonical Conformations in Antibody Hypervariable Loops Using Cyclic Peptides Containing a Heterochiral Diproline Template; J. Am. Chem. Soc.; Mar. 31, 1999, vol. 121, No. 12, pp. 2679-2685.
Obrecht et al.; Novel Peptide Mimetic Building Blocks and Strategies for Efficient Lead Finding; Advances in Medicinal Chemistry, JAI Press, U.S.; Apr. 1999, pp. 1-68.
Robinson; The Design, Synthesis and Conformation of Some New beta-Hairpin Mimetics: Novel Reagents for Drug and Vaccine Discovery; Synlett, vol. 1999, No. 4, Apr. 2000, pp. 429-441.
Jiang et al.; Combinatorial Biomimetic Chemistry: Parallel Synthesis of a Small Library of beta-Haripin Mimetics Based on Loop III from Human Platelet-Derived Growth Factor B; Helvetica Chimica Acta; Vol. No. 83, No. 12, Dec. 2000; pp. 3097-3112.
McInnes; et al.; Development of the structural basis for antimicrobial and hemolytic activities of peptides based on gramicidin S and design of novel analogs using NMR spectroscopy; Journal of Biological Chemistry; Vol. No. 275 No. 19; May 12, 2000; pp. 14287-14294.
Hanessian et al.; Design and Synthesis of Conformationally Constrained Amino Acids as Versatile Scaffolds and Peptides Mimetics; Tetrahedron, Elsevier Science Publishers; Amsterdam, NL; vol. 53, No. 38, Sep. 22, 1997; pp. 12789-12854.
Belvisi et al.; Conformational analysis of azabicycloalkane amino acid scaffolds as reverse-turn inducer dipeptide mimics; Eur. J. Org. Chem.; 2000; vol. 14, pp. 2563-2569.
Pfeifer et al.; Synthesis and solution conformation of beta-hairpin mimetics utilizing a template derived from (2S, 3R, 4R)-diaminoproline; Helv. Chim. Acta; 2000; vol. 83(2); pp. 444-464.
Muller et al.; Are beta-turn mimetics of beta-turns? Angew. Chem. Int. Ed.; 2000; vol. 39(5); pp. 894-896.
Boatman et al.; Secondary Structure Peptide Mimetics: Design, Synthesis, and Evaluation of beta-Strand Mimetic Trombin Inhibitors; J. Med. Chem.; 1999; vol. 42(8), pp. 1367-1375.
Gennari et al.; Solid-phase synthesis of peptides containing reverse-turn mimetic bicyclic lactams; Eur. J. Or. Chem.; 1999; vol. (2); pp. 379-388.
Belvisi et al.; Conformational preferences of peptides containing reverse-turn mimetic bicyclic lactams, Inverse gamma-turns versus type-II beta-turns, Insights into beta-hairpin stability; Eur. J. Org. Chem.; 1999, vol. (2); pp. 389-400.
Pfeifer et al.; Stabilization of beta-hairpin conformations in a protein surface mimetic using a bicyclic template derived from (2S, 3R, 4R)-diaminoproline; Chem. Commun.; Cambridge; 1998. vol. 18, pp. 1977-1978.
Bisang et al.; Synthesis, Conformational Properties, and Immunogenicity of a Cyclic Template-Bound Peptide Mimetic Containing and NPNA Motif from a Circumsporozoite Protein of Plasmodium Falciparum; J. Am. Chem. Soc.; 1998; vol. 120 (30); pp. 7439-7449.
Li et al.; Conformationally Restricted TRH Analogs: The Compatability of a 6, 5-Bicyclic Lactam-Based Mimetic with Binding to TRH-R; J. Am. Chem. Soc.; 1996, vol. 118 (42); pp. 10106-10112.
Obrecht Daniel
Robinson John Anthony
Vrijbloed Jan Wim
Hoffmann & Baron , LLP
Kosar Andrew D.
Polyphor Ltd
Tsang Cecilia J.
LandOfFree
Template-fixed peptidomimetics with antimicrobial activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Template-fixed peptidomimetics with antimicrobial activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Template-fixed peptidomimetics with antimicrobial activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3882203